You have 9 free searches left this month | for more free features.

Daratumumab (JNJ-54767414)

Showing 576 - 600 of 632

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Health Trial in Antwerp (JNJ-40346527/Placebo, JNJ-40346527)

Completed
  • Health
  • Antwerp, Belgium
    (unnamed)
Sep 3, 2013

Histamine Induced Itch Trial in Harrow (A:JNJ-39758979/Placebo #1, C:Cetirizine/JNJ-39758979 Matching Placebo, B: JNJ-39758979

Completed
  • Histamine Induced Itch
  • A:JNJ-39758979/Placebo #1
  • +2 more
  • Harrow, United Kingdom
    (unnamed)
Sep 3, 2013

Seasonal Allergic Rhinitis Trial in Mississauga (JNJ38224342, JNJ38224342/)

Completed
  • Seasonal Allergic Rhinitis
  • Mississauga, Ontario, Canada
    (unnamed)
Sep 3, 2013

Healthy Volunteers Trial (JNJ-39393406, Placebo)

Completed
  • Healthy Volunteers
  • (no location specified)
Jul 23, 2013

Multiple Myeloma Trial in Japan (JNJ-26866138 0.7 mg/m2, JNJ-26866138 1.0 mg/m2, JNJ-26866138 1.3 mg/m2)

Completed
  • Multiple Myeloma
  • JNJ-26866138 0.7 mg/m2
  • +4 more
  • Fukuoka, Japan
  • +27 more
Oct 31, 2013

Healthy Trial in Antwerpen (JNJ-40411813 50 mg, JNJ-40411813 100 mg, Placebo)

Completed
  • Healthy
  • JNJ-40411813 50 mg
  • +2 more
  • Antwerpen, Belgium
    (unnamed)
Aug 27, 2013

Healthy Trial in Groningen (JNJ-40411813)

Completed
  • Healthy
  • Groningen, Netherlands
    (unnamed)
Jul 8, 2013

Diabetes, Type II, Diabetes, Non Insulin Dependent Trial in Worldwide (Canagliflozin (JNJ-28431754), Sitagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type II
  • Diabetes Mellitus, Non Insulin Dependent
  • Canagliflozin (JNJ-28431754)
  • +2 more
  • Birmingham, Alabama
  • +84 more
Jul 15, 2013

Healthy Trial in Neptune (JNJ-38518168 3 mg, JNJ-38518168 30 mg, JNJ-38518168 10 mg)

Completed
  • Healthy
  • JNJ-38518168 3 mg
  • +3 more
  • Neptune, New Jersey
    (unnamed)
Jul 15, 2013

Healthy Participants Trial in Antwerp (JNJ-47910382 (suspension), JNJ-47910382 (tablet))

Completed
  • Healthy Participants
  • JNJ-47910382 (suspension)
  • JNJ-47910382 (tablet)
  • Antwerp, Belgium
    (unnamed)
Jul 22, 2013

Healthy Participants Trial in Antwerp (JNJ-26528398, Placebo)

Completed
  • Healthy Participants
  • Antwerp, Belgium
    (unnamed)
Jun 21, 2013

Healthy Trial in Cypress (JNJ-39439335 10 mg, JNJ-39439335 25 mg, JNJ-39439335 50 mg)

Completed
  • Healthy
  • JNJ-39439335 10 mg
  • +3 more
  • Cypress, California
    (unnamed)
Jun 24, 2013

Obesity Trial in Puerto Rico, United States (Canagliflozin (JNJ-28431754), Placebo)

Completed
  • Obesity
  • Canagliflozin (JNJ-28431754)
  • Placebo
  • Hot Springs, Arkansas
  • +35 more
Apr 1, 2013

Diabetes, Type 2 Trial in Chula Vista, San Antonio (Placebo, JNJ 28431754 300 mg/, JNJ 28431754 100 mg/)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • +2 more
  • Chula Vista, California
  • +1 more
May 27, 2013

Heart Failure Trial in Worldwide (JNJ-39588146 5 ng/kg/min, JNJ-39588146 15 ng/kg/min, JNJ-39588146 30 ng/kg/min)

Completed
  • Heart Failure
  • JNJ-39588146 5 ng/kg/min
  • +4 more
  • Aalst, Belgium
  • +8 more
Jul 8, 2013

Rheumatoid Arthritis Trial in United States (JNJ-38518168 / MTX)

Completed
  • Rheumatoid Arthritis
  • JNJ-38518168 / MTX
  • Anniston, Alabama
  • +3 more
May 3, 2013

Renal Insufficiency, Healthy Trial in Orlando, Minneapolis, Knoxville (Canagliflozin (JNJ-28431754))

Completed
  • Renal Insufficiency
  • Healthy
  • Canagliflozin (JNJ-28431754)
  • Orlando, Florida
  • +2 more
May 27, 2013

Tumors Trial (JNJ-38877605)

Terminated
  • Neoplasms
  • (no location specified)
Mar 7, 2013

Rheumatoid Arthritis Trial in Worldwide (JNJ 38518168, Placebo)

Terminated
  • Rheumatoid Arthritis
  • JNJ 38518168
  • Placebo
  • Liege, Belgium
  • +33 more
Apr 22, 2013

Traumatic Brain Injury Trial in Belgium, France (JNJ-17299425)

Terminated
  • Traumatic Brain Injury
  • Aalst, Belgium
  • +10 more
Apr 30, 2013

Acne Vulgaris Trial in Fukukoka, Hakata (JNJ 10229570-AAA 1.2%, JNJ 10229570-AAA 3.6%, Color-matched vehicle containing 0 mg of

Completed
  • Acne Vulgaris
  • JNJ 10229570-AAA 1.2%
  • +2 more
  • Fukukoka, Japan
  • +1 more
Feb 18, 2013

Hepatitis C Virus Infection Trial in Neuss (JNJ-47910382, Placebo)

Completed
  • Hepatitis C Virus Infection
  • Neuss, Germany
    (unnamed)
Feb 18, 2013

Healthy Trial (Simvastatin, Canagliflozin (JNJ-28431754))

Completed
  • Healthy
  • (no location specified)
Mar 26, 2013

Rheumatoid Arthritis Trial in Germany, United States (JNJ-39758979 / MTX)

Completed
  • Rheumatoid Arthritis
  • JNJ-39758979 / MTX
  • Daytona Beach, Florida
  • +4 more
Mar 12, 2013

Healthy Male Volunteer Trial in Cypress (JNJ-38518168 (30 mg), JNJ-38518168 (10 mg), JNJ-38518168 (3 mg))

Completed
  • Healthy Male Volunteer
  • JNJ-38518168 (30 mg)
  • +4 more
  • Cypress, California
    (unnamed)
Mar 1, 2013